The biotech bi-weekly: genome editing, life-extending therapeutics, an early-stage biotech hub and more
Over the last couple of weeks, the biotech and pharma spaces have been inundated with product launches, partnership announcements, grant awards and breakthrough publications. Here, we highlight an AI platform optimizing biological discovery, a partnership supporting early-stage biotech companies in Korea and a US$2.2 million grant awarded by the Gates Foundation to develop implantable cell factory platforms that can deliver therapeutic antibodies over extended periods of two years or longer. Product Enabling a new genome-engineering strategy Full Circles Therapeutics (MA, USA) recently announced that its circular single-stranded DNA (cssDNA, C4DNA™) technology platform has been highlighted as a key enabling component...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!